Shanghai Allist Pharmaceuticals Co.,Ltd.(688578),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

688578 Shanghai Allist Pharmaceuticals Co.,Ltd.

Closed 12-15 15:00:01

101.12

+1.98

+2.00%

High102.17	Low98.77	Vol3.62M
Open99.05	D1 Closing99.14	Amplitude3.43%
Mkt Cap45.50B	Tradable Cap45.50B	Total Shares450.00M
T/O365.00M	T/O Rate0.80%	Tradable Shares450.00M
P/B7	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688578","market":"SH","secType":"STK","nameCN":"Shanghai Allist Pharmaceuticals Co.,Ltd.","latestPrice":101.12,"timestamp":1765782001000,"preClose":99.14,"halted":0,"volume":3616846,"delay":0,"changeRate":0.02,"floatShares":450000000,"shares":450000000,"eps":4.406,"marketStatus":"Closed","change":1.98,"latestTime":"12-15 15:00:01","open":99.05,"high":102.17,"low":98.77,"amount":365000000,"amplitude":0.0343,"askPrice":101.18,"askSize":1,"bidPrice":101.12,"bidSize":20,"shortable":0,"etf":0,"ttmEps":4.406,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":99.14,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":109.05,"lowLimit":89.23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":7,"roa":"--","peRate":22.950522,"roe":"27.92%","epsLYR":3.18,"committee":-0.450902,"marketValue":45504000000,"turnoverRate":0.008,"status":0,"afterMarket":{"amount":0,"volume":0,"close":101.12,"buyVolume":0,"sellVolume":0,"time":1765784039585,"indexStatus":"Closed 12-15 15:30:00","preClose":99.14},"floatMarketCap":45504000000},"requestUrl":"/m/hq/s/688578","defaultTab":"news","newsList":[{"id":"2589384647","title":"Allist Pharmaceuticals' Two Cancer Drugs Placed on China's Insurance Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=2589384647","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589384647?lang=en_us&edition=fundamental","pubTime":"2025-12-08 14:32","pubTimestamp":1765175524,"startTime":"0","endTime":"0","summary":"Shanghai Allist Pharmaceuticals'  two cancer drugs were included in China's National Drug List for Basic Medical Insurance, Maternity Insurance and Work-Related Injury Insurance list, according to a Monday disclosure on the Shanghai bourse.The drugs included on the list are fumetinib mesylate tablets and golarelisib citrate tablets.The pharmaceutical company's Shanghai shares rose more than 1% during Monday's afternoon trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688578","BK0239"],"gpt_icon":0},{"id":"1190942803","title":"Shanghai Allist Pharmaceuticals (688578.SH): Innovative Drugs Fumetinib and Goleritinib Included in Updated National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1190942803","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190942803?lang=en_us&edition=fundamental","pubTime":"2025-12-07 16:08","pubTimestamp":1765094893,"startTime":"0","endTime":"0","summary":"Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) announced that its innovative drugs, Fumetinib Mesylate Tablets (brand name \"Aifusha®\") and Goleritinib Citrate Tablets (brand name \"Airuikai®\"),...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","688578","06978","BK1574","BK0239","BK1161"],"gpt_icon":0},{"id":"1185038216","title":"Shanghai Allist Pharmaceuticals Achieves Annual Production Capacity of 200 Million Fuzulatinib Mesylate Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1185038216","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185038216?lang=en_us&edition=fundamental","pubTime":"2025-11-28 20:01","pubTimestamp":1764331272,"startTime":"0","endTime":"0","summary":"An investor inquired on the interactive platform regarding the production capacity of Fuzulatinib Mesylate tablets and the utilization rate of the two production lines in November. Shanghai Allist...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688578","BK0239"],"gpt_icon":0},{"id":"1155049531","title":"Shanghai Allist Pharmaceuticals Completes Board Reelection, Du Jinhao Appointed as Chairman and General Manager","url":"https://stock-news.laohu8.com/highlight/detail?id=1155049531","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155049531?lang=en_us&edition=fundamental","pubTime":"2025-11-27 21:21","pubTimestamp":1764249700,"startTime":"0","endTime":"0","summary":"Shanghai Allist Pharmaceuticals Co.,Ltd. (688578) announced that it held the first meeting of its third board of directors on November 27, 2025, electing the chairman, vice chairman, and members of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688578"],"gpt_icon":0},{"id":"1158988113","title":"Shanghai Allist Pharmaceuticals (688578.SH) Reports Q3 Earnings: Net Profit Up 52.01% YoY to RMB 1.616 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1158988113","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158988113?lang=en_us&edition=fundamental","pubTime":"2025-10-29 01:50","pubTimestamp":1761673811,"startTime":"0","endTime":"0","summary":"Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) released its third-quarter financial report for 2025. The company achieved total revenue of RMB 3.733 billion in the first three quarters,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688578"],"gpt_icon":0},{"id":"2578693720","title":"Shanghai Allist Pharmaceuticals Q3 Net Profit Up 38.8% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2578693720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578693720?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:45","pubTimestamp":1761648314,"startTime":"0","endTime":"0","summary":"Oct 28 (Reuters) - Shanghai Allist Pharmaceuticals Co Ltd <688578.SS>::*SAYS Q3 NET PROFIT UP 38.8% Y/Y  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 28-OCT-202510:34:13 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nRSDBqJ6N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688578","BK0239"],"gpt_icon":0},{"id":"1109875135","title":"Shanghai's GDP Growth Outpaces National Rate in First Three Quarters: What Drives This Momentum?","url":"https://stock-news.laohu8.com/highlight/detail?id=1109875135","media":"Deep News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109875135?lang=en_us&edition=fundamental","pubTime":"2025-10-22 11:31","pubTimestamp":1761103860,"startTime":"0","endTime":"0","summary":"In the first three quarters of 2025, Shanghai's GDP reached 40.721 trillion yuan, reflecting a year-on-year increase of 5.5% at constant prices, which is 0.4 percentage points higher than the growth...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"485c0dd740c75b1ee6ec990c688a7b96","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688578","BK0239"],"gpt_icon":0},{"id":"1164605363","title":"Significant Increase in Shanghai Allist Pharmaceuticals Holdings - Ge Lan: Continuing to Focus on Innovative Drug Investment Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1164605363","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164605363?lang=en_us&edition=fundamental","pubTime":"2025-09-01 17:21","pubTimestamp":1756718518,"startTime":"0","endTime":"0","summary":"According to financial reports, on August 30th, the China Europe Healthcare Fund managed by Ge Lan and Zhao Lei released its 2025 interim report. As of August 29th, the fund achieved a year-to-date...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688578","BK0239","159992","BK1574","06978"],"gpt_icon":0},{"id":"1197220901","title":"Shanghai Allist Pharmaceuticals Reports Strong H1 2025 Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1197220901","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197220901?lang=en_us&edition=fundamental","pubTime":"2025-08-28 11:11","pubTimestamp":1756350683,"startTime":"0","endTime":"0","summary":"Shanghai Allist Pharmaceuticals Co.,Ltd. recently announced its first half 2025 financial results, demonstrating robust growth across key metrics. The company recorded operating revenue of 23.74...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688578","BK0239"],"gpt_icon":0},{"id":"1140359678","title":"Shanghai Allist Pharmaceuticals Co.,Ltd. (688578.SH) Reports Semi-Annual Results with Net Profit of 10.51 Billion Yuan, Up 60.22% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1140359678","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140359678?lang=en_us&edition=fundamental","pubTime":"2025-08-26 17:14","pubTimestamp":1756199658,"startTime":"0","endTime":"0","summary":"Shanghai Allist Pharmaceuticals Co.,Ltd. (688578.SH) released its semi-annual report for 2025, showing strong financial performance during the reporting period. The company achieved revenue of 23.74...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688578"],"gpt_icon":0},{"id":"2562855507","title":"BRIEF-Shanghai Allist Pharmaceuticals H1 Net Profit Up 60.2% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2562855507","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562855507?lang=en_us&edition=fundamental","pubTime":"2025-08-26 16:18","pubTimestamp":1756196299,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Allist Pharmaceuticals H1 Net Profit Up 60.2% Y/YAug 26 (Reuters) - Shanghai Allist Pharmaceuticals Co Ltd 688578.SS:SAYS H1 NET PROFIT UP 60.2% Y/YSource textFurther company coverage: 688578.SS (Reporting by Beijing Newsroom) ((Xiuhao.Chen@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nL4N3UI0JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688578","BK0239"],"gpt_icon":0},{"id":"1128157469","title":"ABBISKO-B (02256): IND Application for Combination Therapy of Oral PD-L1 Inhibitor ABSK043 and Shanghai Allist's KRAS G12C Inhibitor for NSCLC Treatment Receives CDE Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1128157469","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128157469?lang=en_us&edition=fundamental","pubTime":"2025-08-20 19:31","pubTimestamp":1755689504,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that the IND application for combination therapy using its subsidiary's investigational oral PD-L1 inhibitor ABSK043 and Shanghai Allist Pharmaceuticals Co.,Ltd.'s KRAS...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4023","BK1515","688578","BK1574","LU1223082519.USD","LU1223083913.SGD","LU2488822045.USD","BK0239","PD","BK4017","LU1169590202.USD","02256","LU1223082196.USD","LU1169589451.USD","09939","CDE","159938"],"gpt_icon":0},{"id":"2557529852","title":"BRIEF-Shanghai Allist Pharmaceuticals' Shareholders To Unload Stakes","url":"https://stock-news.laohu8.com/highlight/detail?id=2557529852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557529852?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:27","pubTimestamp":1754652448,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Allist Pharmaceuticals' Shareholders To Unload StakesAug 8  - Shanghai Allist Pharmaceuticals Co Ltd 688578.SS:SAYS SHAREHOLDERS PLAN TO UNLOAD UP TO COMBINED 3% STAKES IN CO BETWEEN SEPTEMBER 1 AND NOVEMBER 30Source textFurther company coverage: 688578.SS  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL4N3U01G5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688578","BK0239"],"gpt_icon":0},{"id":"2557526774","title":"Shanghai Allist Pharmaceuticals  Says Shareholders Plan to Unload up to Combined 3% Stakes in Co Between September 1 and November 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2557526774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557526774?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:27","pubTimestamp":1754652448,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL4N3U01G5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688578","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-12-02","address":"上海市浦东新区周浦镇凌霄花路268号","stockEarnings":[{"period":"1week","weight":0.0298},{"period":"1month","weight":-0.0238},{"period":"3month","weight":-0.1287},{"period":"6month","weight":0.0434},{"period":"1year","weight":0.605},{"period":"ytd","weight":0.6677}],"companyName":"上海艾力斯医药科技股份有限公司","boardCode":"AI0027","perCapita":"23551股","boardName":"医药制造业","registeredCapital":"45000万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　上海艾力斯医药科技股份有限公司的主营业务是肿瘤治疗领域的创新药研发、生产及销售。公司的主要产品是甲磺酸伏美替尼片、枸橼酸戈来雷塞片、普拉替尼胶囊。公司于2023年获评“中国医药创新企业100强”，并荣获上海市创新型企业总部认定授牌。2024年3月，公司荣登“2023中国创新药上市公司价值引领TOP15”榜单。2024年4月，公司荣获浦东新区“2023年度科技创新突出贡献奖”。2024年10月，公司获得上海市第32批市级企业技术中心认定。2025年4月，公司获得“2024年度浦东新区先进制造业突出贡献奖”。2025年6月，公司获得第二十五届中国专利金奖。","serverTime":1765796011955,"listedPrice":22.73,"stockholders":"19107人(较上一季度增加46.82%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shanghai Allist Pharmaceuticals Co.,Ltd.(688578),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shanghai Allist Pharmaceuticals Co.,Ltd.(688578) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shanghai Allist Pharmaceuticals Co.,Ltd.,688578,Shanghai Allist Pharmaceuticals Co.,Ltd.股票,Shanghai Allist Pharmaceuticals Co.,Ltd.股票老虎,Shanghai Allist Pharmaceuticals Co.,Ltd.股票老虎国际,Shanghai Allist Pharmaceuticals Co.,Ltd.行情,Shanghai Allist Pharmaceuticals Co.,Ltd.股票行情,Shanghai Allist Pharmaceuticals Co.,Ltd.股价,Shanghai Allist Pharmaceuticals Co.,Ltd.股市,Shanghai Allist Pharmaceuticals Co.,Ltd.股票价格,Shanghai Allist Pharmaceuticals Co.,Ltd.股票交易,Shanghai Allist Pharmaceuticals Co.,Ltd.股票购买,Shanghai Allist Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shanghai Allist Pharmaceuticals Co.,Ltd.(688578),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shanghai Allist Pharmaceuticals Co.,Ltd.(688578) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction